Alzheimer's Drug Discovery Foundation
Research Services • 
Manhattan, New York, United States • 51-100 Employees
Company overview
| Headquarters | 57 West 57th Street, Suite 904, New York, NY 10019, US |
| Phone number | +12129018000 |
| Website | |
| NAICS | 5417 |
| SIC | 839 |
| Keywords | Neuroscience, Drug Discovery, Biomarker Development, Cognitive Aging |
| Founded | 1998 |
| Employees | 51-100 |
| Socials |
Key Contacts at Alzheimer's Drug Discovery Foundation
Mark Roithmayr
Chief Executive Officer
Howard Fillit
Co-Founder And Chief Science Officer
Eli Shobin
Head Of The Diagnostics Accelerator, Sr Director
Chandra Gruber
Director Of Grants Management
Laura Nisenbaum
Executive Director, Drug Development
Shobha Purushothama
Sr. Director, Biomarkers
Alexandra Brackenheimer
Assistant Director
Yuko Hara
Director, Aging And Alzheimer'S Prevention
Elizabeth Mills
Assistant Director, Aging And Alzheimer'S Prevention
Marina D'Emic
Director Of Finance
Alzheimer's Drug Discovery Foundation Email Formats
Alzheimer's Drug Discovery Foundation uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@alzdiscovery.org), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@alzdiscovery.org | 60% |
{first initial}{last name} | jdoe@alzdiscovery.org | 40% |
About Alzheimer's Drug Discovery Foundation
Conquering Alzheimer’s Through Drug Discovery. Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) was one of the first charities to adopt the venture philanthropy model. Our mission is to rapidly accelerate the discovery of drugs to prevent and treat Alzheimer’s disease and related dementias. We are the only charity focused solely on supporting new drugs for Alzheimer’s. The ADDF’s in-house team of six expert neuroscientists identifies and funds the most promising research initiatives around the world. They work to ensure that every viable option to prevent or treat Alzheimer’s is explored, and that the pipeline of drugs in development for Alzheimer’s is both diverse and robust. Since 1998, we have awarded over $100 million to fund more than 550 Alzheimer’s drug discovery programs and clinical trials in 18 countries. Today, 20% of all treatments for Alzheimer’s in clinical trials have received support from the ADDF.
Alzheimer's Drug Discovery Foundation revenue & valuation
| Annual revenue | $7,319,658 |
| Revenue per employee | $102,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $23,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Alzheimer's Drug Discovery Foundation has 20 employees across 10 departments.
Departments
Number of employees
Funding Data
Alzheimer's Drug Discovery Foundation has never raised funding before.
Alzheimer's Drug Discovery Foundation Tech Stack
Discover the technologies and tools that power Alzheimer's Drug Discovery Foundation's digital infrastructure, from frameworks to analytics platforms.
CDN
Security
Web frameworks
CMS
JavaScript libraries
JavaScript libraries
JavaScript libraries
Programming languages
Security
Appointment scheduling
Analytics
Germany
ItalyFrequently asked questions
4.8
40,000 users
